232 related articles for article (PubMed ID: 16870280)
1. Pathological importance of anti-G-protein coupled receptor autoantibodies.
Matsui S; Fu M
Int J Cardiol; 2006 Sep; 112(1):27-9. PubMed ID: 16870280
[TBL] [Abstract][Full Text] [Related]
2. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
Jahns R; Boivin V; Lohse MJ
Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
[TBL] [Abstract][Full Text] [Related]
3. Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function.
Matsui S; Larsson L; Hayase M; Katsuda S; Teraoka K; Kurihara T; Murano H; Nishikawa K; Fu M
J Mol Cell Cardiol; 2006 Jul; 41(1):78-85. PubMed ID: 16780870
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities.
Chiale PA; Rosenbaum MB; Elizari MV; Hjalmarson A; Magnusson Y; Wallukat G; Hoebeke J
J Am Coll Cardiol; 1995 Oct; 26(4):864-9. PubMed ID: 7560610
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.
Levin MJ; Hoebeke J
Autoimmunity; 2008 Sep; 41(6):429-33. PubMed ID: 18781468
[TBL] [Abstract][Full Text] [Related]
6. DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice.
Giménez LE; Hernández CC; Mattos EC; Brandão IT; Olivieri B; Campelo RP; Araújo-Jorge T; Silva CL; Campos de Carvalho AC; Kurtenbach E
J Mol Cell Cardiol; 2005 May; 38(5):703-14. PubMed ID: 15850564
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?
Fu M
Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466
[TBL] [Abstract][Full Text] [Related]
8. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.
Jahns R; Boivin V; Lohse MJ
Trends Cardiovasc Med; 2006 Jan; 16(1):20-4. PubMed ID: 16387626
[TBL] [Abstract][Full Text] [Related]
9. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
Dandel M; Wallukat G; Potapov E; Hetzer R
Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
[TBL] [Abstract][Full Text] [Related]
10. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
[TBL] [Abstract][Full Text] [Related]
11. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study.
Deubner N; Berliner D; Schlipp A; Gelbrich G; Caforio AL; Felix SB; Fu M; Katus H; Angermann CE; Lohse MJ; Ertl G; Störk S; Jahns R;
Eur J Heart Fail; 2010 Jul; 12(7):753-62. PubMed ID: 20494925
[TBL] [Abstract][Full Text] [Related]
12. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.
Magnusson Y; Marullo S; Hoyer S; Waagstein F; Andersson B; Vahlne A; Guillet JG; Strosberg AD; Hjalmarson A; Hoebeke J
J Clin Invest; 1990 Nov; 86(5):1658-63. PubMed ID: 1700798
[TBL] [Abstract][Full Text] [Related]
13. Myocardial injury due to G-protein coupled receptor-autoimmunity.
Matsui S; Fu ML
Jpn Heart J; 1998 May; 39(3):261-74. PubMed ID: 9711178
[TBL] [Abstract][Full Text] [Related]
14. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
16. Aptamer BC 007 - A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors.
Haberland A; Holtzhauer M; Schlichtiger A; Bartel S; Schimke I; Müller J; Dandel M; Luppa PB; Wallukat G
Eur J Pharmacol; 2016 Oct; 789():37-45. PubMed ID: 27375076
[TBL] [Abstract][Full Text] [Related]
17. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy?
Arndt-Marić R; Nägele H; Schewe G; Kromminga A
Clin Lab; 2010; 56(11-12):519-26. PubMed ID: 21141435
[TBL] [Abstract][Full Text] [Related]
18. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R
Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841
[TBL] [Abstract][Full Text] [Related]
19. [Role of Autoantibodies Against 1-Adrenergic Receptor in Cardiovascular Disease].
Kostyukevich MV; Zykov KA; Mironova NA; Agapova OY; Shevelev AY; Efremov EE; Vlasik TN; Golitsyn SP
Kardiologiia; 2016 Dec; 56(12):82-91. PubMed ID: 28290809
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody.
Larsson L; Mobini R; Aukrust P; Gullestad L; Wallukat G; Waagstein F; Fu M
Autoimmunity; 2004; 37(6-7):489-93. PubMed ID: 15621576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
